 |
4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| USA Market Approval | USA |
| USA Designation Date | 2005-12-12 00:00:00 |
| Sponsor | Teva Branded Pharmaceutical Products R&D;;41 Moores Road;Frazer, Pennsylvania, 19355 |
Related Access Program